Genetic Sequencing tests in Dubai & UAE

Compare available Genetic Sequencing tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

256

Listed price range

2,600.00–5,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Genetic Sequencing test prices

Showing 31–45 of 256 matching tests.

Genetic Sequencing diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-5345 C2 Deficiency (C2 Gene) Next-Generation Sequencing Test This test identifies pathogenic variants in the C2 gene, which encodes the complement component 2 protein.	Blood (Whole Blood)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the C2 gene", "Complement component 2 protein encoding"] Parameters [] Preparation [] Indications ["Suspected C2 deficiency", "Recurrent infections", "Autoimmune disorders", "Family history of C2 deficiency"] Measurement technique Confirm with laboratory Codes LOINC: 94226-8 ICD-10: D84.1 Clinical summary This test identifies pathogenic variants in the C2 gene, which encodes the complement component 2 protein.
TEST-2464 C2CD3 Gene Orofaciodigital Syndrome Type 14 Genetic Test This diagnostic test evaluates for pathogenic variants within the C2CD3 gene associated with Orofaciodigital Syndrome Type 14.	Peripheral Whole Blood / Dried Blood Spot (DBS)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["C2CD3 gene mutations", "Point mutations", "Indels", "Copy-number variants"] Parameters [] Preparation [] Indications ["Individuals with clinical features suggestive of OFD14", "Families with a history of syndromic congenital conditions"] Measurement technique Confirm with laboratory Codes LOINC: 95039-2 ICD-10: Q87.0 Clinical summary This diagnostic test evaluates for pathogenic variants within the C2CD3 gene associated with Orofaciodigital Syndrome Type 14.
TEST-3952 CALCRL Gene Genetic Test This genetic test evaluates the CALCRL gene for pathogenic variants associated with hereditary vascular system defects.	Whole Blood / Extracted DNA / FTA Card (One Drop)	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CALCRL gene variants", "Pathogenic mutations"] Parameters [] Preparation ["No specific medication or supplement avoidance required", "Mandatory pre-test genetic counseling session required", "No fasting necessary"] Indications ["Personal or family history of unexplained vascular malformations", "Early-onset vascular events", "Known familial predisposition to vascular disorders", "Asymptomatic adult family members of a proband with a confirmed CALCRL pathogenic variant"] Measurement technique Confirm with laboratory Codes LOINC: 21665-7 ICD-10: Q27.8 Clinical summary This genetic test evaluates the CALCRL gene for pathogenic variants associated with hereditary vascular system defects.
TEST-4110 CALM1 Gene Catecholaminergic Polymorphic Ventricular Tachycardia Type 4 (CPVT4) Genetic Test This genetic test analyzes the CALM1 gene to identify variants associated with Catecholaminergic Polymorphic Ventricular Tachycardia Type 4 (CPVT4).	Peripheral Whole Blood (3–5 mL in EDTA tube) or Buccal Swab / FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CALM1 gene sequence", "Pathogenic variants in CALM1"] Parameters [] Preparation ["No fasting required", "No medication adjustment required"] Indications ["Suspected CPVT4", "Family history of CPVT4", "Risk stratification for sudden cardiac death"] Measurement technique Confirm with laboratory Codes LOINC: 81313-8 ICD-10: I47.2 Clinical summary This genetic test analyzes the CALM1 gene to identify variants associated with Catecholaminergic Polymorphic Ventricular Tachycardia Type 4 (CPVT4).
TEST-3776 CASR Gene Hypocalciuric Hypercalcemia Type 1 Genetic Test This test identifies genetic variants in the CASR gene associated with Familial Hypocalciuric Hypercalcemia Type 1 (FHH1). It helps confirm the diagnosis and differentiate FHH1 fro...	Whole blood (EDTA), extracted DNA, or FTA card blood spot	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the CASR gene", "Calcium metabolism regulation"] Parameters [{"name": "Genomic Coverage", "reference_range": "Full coding region, splice sites, and selected deep intronic regions; variant detection down to 5% allele frequency"}, {"name": "Methodology", "reference_range": "Next-Generation Sequencing (NGS) with bioinformatic annotation and ACMG/AMP variant classification"}, {"name": "Turnaround Time", "reference_range": "3–4 weeks with expedited clinical reporting"}] Preparation ["No specific fasting required", "Do not discontinue calcium-regulating medications without physician instruction"] Indications ["Diagnosis of Familial Hypocalciuric Hypercalcemia Type 1 (FHH1)", "Differentiation from primary hyperparathyroidism", "Cascade screening of family members"] Measurement technique Confirm with laboratory Codes LOINC: 74823-8 ICD-10: E83.52 Clinical summary This test identifies genetic variants in the CASR gene associated with Familial Hypocalciuric Hypercalcemia Type 1 (FHH1). It helps confirm the diagnosis and differentiate FHH1 from other causes of hypercalcemia.
TEST-4114 CAV3 Gene Mutation Analysis (NGS) for Elevated Serum Creatine Kinase (CPK) Test This test identifies mutations in the CAV3 gene associated with elevated serum creatine kinase levels and related neuromuscular disorders.	Peripheral Whole Blood	3-4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CAV3 gene mutations", "Pathogenic variants"] Parameters [] Preparation ["A mandatory pretest genetic counseling session is required.", "Avoid strenuous exercise for 24 hours before sample collection."] Indications ["Unexplained hyperCKemia", "Suspected caveolinopathy", "Family history of neuromuscular disorders"] Measurement technique Confirm with laboratory Codes LOINC: 95209-3 ICD-10: R74.8 Clinical summary This test identifies mutations in the CAV3 gene associated with elevated serum creatine kinase levels and related neuromuscular disorders.
TEST-2290 CBFB Gene Skeletal Abnormalities Genetic Test This test evaluates the CBFB gene for pathogenic variants associated with skeletal dysplasias and dysmorphology.	Peripheral Whole Blood, Extracted DNA, One‑drop FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the CBFB gene"] Parameters [] Preparation [] Indications ["Diagnosis of congenital skeletal dysplasias", "Diagnosis of dysmorphology", "Confirmation of cleidocranial dysplasia-spectrum disorders"] Measurement technique Confirm with laboratory Codes LOINC: 81247-9 ICD-10: Q78.8 Clinical summary This test evaluates the CBFB gene for pathogenic variants associated with skeletal dysplasias and dysmorphology.
TEST-4119 CC2D2A Gene COACH Syndrome Genetic Test This test analyzes the CC2D2A gene for variants associated with COACH syndrome.	Peripheral Whole Blood	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CC2D2A gene variants", "Pathogenic mutations"] Parameters [] Preparation [] Indications ["Suspected COACH syndrome", "Confirmation of clinical diagnosis", "Family planning"] Measurement technique Confirm with laboratory Codes LOINC: 55233-1 ICD-10: Q87.8 Clinical summary This test analyzes the CC2D2A gene for variants associated with COACH syndrome.
TEST-5051 CCBE1 Gene Analysis (Hennekam Lymphangiectasia‑Lymphedema Syndrome Type 1) Test This genetic test detects pathogenic DNA variants in the entire coding region of the CCBE1 gene, confirming the molecular cause of Hennekam syndrome type 1.	Peripheral Whole Blood (EDTA) or Dried Blood Spot (FTA Card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic DNA variants in the CCBE1 gene"] Parameters [] Preparation ["No fasting is required."] Indications ["Suspected Hennekam lymphangiectasia‑lymphedema syndrome type 1", "Family history of Hennekam syndrome type 1"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: Q87.8 Clinical summary This genetic test detects pathogenic DNA variants in the entire coding region of the CCBE1 gene, confirming the molecular cause of Hennekam syndrome type 1.
TEST-5992 CDAN1 Gene Anemia Dyserythropoietic Type 1A Genetic Test This test evaluates the CDAN1 gene for variants associated with Congenital Dyserythropoietic Anemia Type 1A (CDA I). It identifies SNVs, indels, and copy number variations within t...	Whole Blood (EDTA), Extracted Genomic DNA, FTA Card Dried Blood Spot	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CDAN1 gene variants", "SNVs", "Indels", "Copy Number Variations"] Parameters [] Preparation ["Do not discontinue prescribed medication without consulting haematologist"] Indications ["Suspected Congenital Dyserythropoietic Anemia Type 1A", "Family history of CDA Type I", "Carrier screening"] Measurement technique Confirm with laboratory Codes LOINC: 81303-1 ICD-10: D64.0 Clinical summary This test evaluates the CDAN1 gene for variants associated with Congenital Dyserythropoietic Anemia Type 1A (CDA I). It identifies SNVs, indels, and copy number variations within the gene.
TEST-4666 CDSN Gene Peeling Skin Syndrome Type 1 Genetic Test This genetic test analyzes the CDSN gene to detect mutations associated with Peeling Skin Syndrome Type 1.	Whole Blood, Extracted DNA, FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CDSN gene sequence", "Pathogenic variants (point mutations, indels, splice variants, CNVs)"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any current anticoagulant therapy"] Indications ["Suspected Peeling Skin Syndrome Type 1", "Family history of Peeling Skin Syndrome Type 1"] Measurement technique Confirm with laboratory Codes LOINC: 94229-4 ICD-10: Q82.8 Clinical summary This genetic test analyzes the CDSN gene to detect mutations associated with Peeling Skin Syndrome Type 1.
TEST-5680 CEACAM16 Gene Deafness Autosomal Dominant Type 4B Genetic Test This test identifies pathogenic variants in the CEACAM16 gene associated with autosomal dominant deafness type 4B.	Whole Blood (EDTA), DNA Extract, or Dried Blood Spot (FTA Card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the CEACAM16 gene", "Copy Number Variations (CNV) in the CEACAM16 gene"] Parameters [] Preparation ["No fasting required", "No medication changes required"] Indications ["Suspected autosomal dominant deafness type 4B", "Family history of hearing loss", "Genetic counseling for hearing loss"] Measurement technique Confirm with laboratory Codes LOINC: 55233-1 ICD-10: H90.5 Clinical summary This test identifies pathogenic variants in the CEACAM16 gene associated with autosomal dominant deafness type 4B.
TEST-4678 CEP290 Gene Sequencing (Joubert Syndrome Type 5) Test This test identifies pathogenic variants in the CEP290 gene, confirming a molecular diagnosis for Joubert syndrome type 5.	Peripheral Whole Blood, FTA Card, or Extracted DNA	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the CEP290 gene"] Parameters [] Preparation ["Provide a complete three-generation pedigree chart", "Provide a neurological examination summary", "Consult physician regarding anticoagulant therapy"] Indications ["Suspected Joubert syndrome type 5", "Family cascade testing"] Measurement technique Confirm with laboratory Codes LOINC: 79016-0 ICD-10: Q04.3 Clinical summary This test identifies pathogenic variants in the CEP290 gene, confirming a molecular diagnosis for Joubert syndrome type 5.
TEST-2349 CEP63 Gene Seckel Syndrome Type 6 Genetic Test This test identifies pathogenic variants in the CEP63 gene associated with Seckel syndrome type 6.	Whole Blood (EDTA tube), previously extracted DNA, or dried blood spot on FTA card	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CEP63 gene variants", "Single-nucleotide variants", "Small insertions/deletions"] Parameters [] Preparation ["Pre-test genetic counselling is mandatory."] Indications ["Suspected Seckel syndrome type 6", "Confirmation of clinical diagnosis"] Measurement technique Confirm with laboratory Codes LOINC: 81261-6 ICD-10: Q87.1 Clinical summary This test identifies pathogenic variants in the CEP63 gene associated with Seckel syndrome type 6.
TEST-4975 CERS3 Gene Sequencing for Autosomal Recessive Congenital Ichthyosis Type 9 (ARCI9) Test This test identifies mutations in the CERS3 gene to confirm a diagnosis of autosomal recessive congenital ichthyosis type 9 (ARCI9).	Peripheral whole blood (EDTA tube), FTA card, or extracted DNA sample	3 – 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CERS3 gene mutations", "Single-nucleotide variants", "Small insertions/deletions", "Copy-number variants"] Parameters [] Preparation ["Resolve any active infections before sample collection.", "Obtain physician clearance if taking anticoagulant therapy."] Indications ["Diagnostic confirmation of ARCI9", "Carrier screening", "Family risk assessment"] Measurement technique Confirm with laboratory Codes LOINC: 48018-6 ICD-10: Q80.8 Clinical summary This test identifies mutations in the CERS3 gene to confirm a diagnosis of autosomal recessive congenital ichthyosis type 9 (ARCI9).

Category overview

Genetic Sequencing: overview

Achieving a definitive diagnosis for multi-system or exceptionally rare disorders requires reading the deepest layers of your foundational biological code. As the pinnacle of our advanced Genetics department, Genetic Sequencing (including Whole Exome or Whole Genome testing) provides an incredibly detailed, high-resolution scan of your DNA. By leveraging state-of-the-art Next-Generation Sequencing technology, this expansive molecular screening helps uncover elusive genetic variants that standard tests miss, safely guiding your healthcare provider in tailoring highly personalized medical treatments and opening doors to advanced precision medicine. Consistently trusted for advanced genomic analysis across premier diagnostic labs in Dubai and the UAE, DNA Labs ensures strict patient confidentiality, exceptional analytical precision, and highly efficient reporting. Secure the definitive insights your health requires—book your genetic sequencing testing in UAE, arrange a secure clinical sample collection, or consult our dedicated medical genetics experts.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.